Mentor wades in to cosmetic surgery battle

Citigroup and Goldman Sachs are advising Mentor, a maker of cosmetic surgery products, on a hostile $2.2bn (€1.9bn) bid for rival Medicis Pharmaceutical in the latest development of a takeover drama that now involves four companies.

Mentor launched a stock bid yesterday which offers Medicis shareholders a 25% premium for their shares.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump